The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Long-term tacrine (Cognex) treatment: Effects on nursing home placement and mortality
Abstract
OBJECTIVE: To assess the possible association between tacrine (Cognex, manufactured by Parke-Davis, Morris Plains, NJ) dose and likelihood of nursing home placement (NHP) or death in patients with AD. DESIGN: A 30-week, randomized, double-blind, placebo-controlled, parallel-group multicenter clinical trial involving 663 patients, after which patients were treated openly and followed up a minimum of 2 years later. PATIENTS: At baseline, outpatients were at least 50 years of age, met criteria for probable AD, with baseline Mini-Mental State Examination scores between 10 and 26 (inclusive), were otherwise healthy, and had a caregiver who could provide assessments and ensure medication compliance. INTERVENTIONS: mandomized assignment to placebo or one of three ascending dosage regimens of tacrine over 30 weeks, followed by open label treatment for all patients who began the double-blind trial. OUTCOME MEASURES: NHP and death were examined using logistic regression. RESULTS: PATIENTS who remained on tacrine and were receiving doses > 80 mg/d or > 120 mg/d were less likely to have entered a nursing home than patients on lower doses (odds ratios > 2.7,2.8, respectively.) There was a trend for lower mortality for patients receiving > 120 mg/d (p = 0.063). CONCLUSIONS: Treatment with tacrine at doses > 80 mg/d was associated with a reduced likelihood of NHP. These data demonstrate that tacrine's 30-week effects on cognitive function and clinicians' global ratings may generalize to effects on a major milestone of AD. Future studies should attempt to replicate these findings prospectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knapp, M. J. (1994) · JAMA · doi:10.1001/jama.271.13.985 · Cited by 1,004
Behavioral Disturbance in Dementia of the Alzheimer's Type
Teri, L., Larson, E. B., & Reifler, B. V. (1988) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1988.tb03426.x · Cited by 406
Predictors of Institutionalization Among Caregivers of Patients With Alzheimer's Disease
Colerick, E. J., & George, L. K. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04239.x · Cited by 392
Genesis and evolution of behavioral disorders: from infancy to early adult life
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.1.1 · Cited by 329
Incontinence and Troublesome Behaviors Predict Institutionalization in Dementia
O'Donnell, B. F., Drachman, D. A., Barnes, H. J., Peterson, K. E., Swearer, J. M., & Lew, R. A. (1992) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099200500108 · Cited by 297 · cited 1×
“At follow-~p Institutionalized or dead 46 (45) 21 (22) 26 (21) 13 (13) 9 (10) 7 (6)”
Maggioni, A. P., Franzosi, M. G., Santoro, E., White, H., Van de Werf, F., & Tognoni, G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207023270101 · Cited by 281
Subjective Memory Complaints and Personality Traits in Normal Elderly Subjects
Hänninen, T., Reinikainen, K. J., Helkala, E., Koivisto, K., Mykkänen, L., Laakso, M., Pyörälä, K., & Riekkinen, P. J. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06064.x · Cited by 232
Brodaty, H. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540060073021 · Cited by 221
Chui, H. C., Lyness, S. A., Sobel, E., & Schneider, L. S. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540190056015 · Cited by 216
Self-citationEffect of Tacrine on Behavioral Symptoms in Alzheimer's Disease: An Open-Label Study
Kaufer, D. I., Cummings, J. L., & Christine, D. (1996) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879600900101 · Cited by 206
Developing improved observational methods for evaluating therapeutic effectiveness
Horwitz, R. I., Viscoli, C. M., Clemens, J. D., & Sadock, R. T. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90182-d · Cited by 204
Welch, H. G., Walsh, J. S. A., & Larson, E. B. B. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb02072.x · Cited by 154
Davey Smith, G., Phillips, A. N., & Neaton, J. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)92242-8 · Cited by 149
Cohler, B. J., ROBBINS, D. M., Hartman, C. R., Shader, R. I., Grunebaum, H. U., Gallant, D. H., & Weiss, J. L. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90017-5 · Cited by 132
Factors Affecting Decisions to Institutionalize Demented Elderly
Lieberman, M. A., & Kramer, J. H. (1991) · The Gerontologist · doi:10.1093/geront/31.3.371 · Cited by 129 · cited 1×
“Days to event 258-671 Range 15-863 138-84 1 172-772 113-755 133-726 - - 25th Percentile* 303 747 742 On other investigational medications Yes 0 ( 0 ) 0 (0) 0 ( 0 ) 0 ( 0 ) 0 (0) 0 ( 0 ) Not stated 4 (4) 3 (3) 0 ( 0 ) 13 (13) 3 (3) l (1)”
Tacrine alters the secretion of the beta‐amyloid precursor protein in cell lines
Lahiri, D. K., Lewis, S., & Farlow, M. R. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370612 · Cited by 118
Overview: the sex of the therapist
MOGUL, K. M. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.1.1 · Cited by 92
Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial
Maltby, N. H., Broe, G. A., Creasey, H. M., Jorm, A. F., Christensen, H. M., & Brooks, W. S. (1994) · BMJ · doi:10.1136/bmj.308.6933.879 · Cited by 88
Effect of long-term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET
Nordberg, A. K. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04259.x · Cited by 42
Long-term treatment with tacrine (THA) in Alzheimer's disease-evaluation of neuropsychological data
Amberla, K., Nordberg, A. K., Viitanen, M. H., & Winblad, B. G. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04257.x · Cited by 37
Cited by
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198
Neuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970
Patient and Caregiver Characteristics and Nursing Home Placement in Patients With Dementia
Yaffe, K. (2002) · JAMA · doi:10.1001/jama.287.16.2090 · Cited by 903
Bartus, R. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7397 · Cited by 829
Metadata
- Authors
- Knopman, D., Schneider, L., Davis, K., Talwalker, S., Smith, F., Hoover, T., & Gracon, S.
- Venue
- Neurology
- Published
- 1996-07
- Volume
- 47
- Issue
- 1
- Pages
- 166-177
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2065052203
- Cited by
- 293
- References
- 20
- FWCI
- 33.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.